- Senior Investigator, Biostatistics Branch
Dr. Philip Rosenberg received a Ph.D. in biostatistics from Yale University. He joined the NCI as a Staff Fellow in 1988, and became a Senior Investigator within the Biostatistics Branch in 1997. Dr. Rosenberg’s research focuses on advancing medical science by testing clinical, epidemiological, and biological hypotheses using state-of-the-art statistical methods. Dr. Rosenberg has received numerous awards for his work in biostatistics, including the Howard W. Temin Award for his contribution to the development of statistical methods to monitor trends in the HIV. He has received NIH Merit Awards for his collaborative work on inherited bone marrow failure syndromes, as well as for pioneering methods and software tools to identify candidate genes and pathways.
- (2020). Incidence of Hip Fracture Over 4 Decades in the Framingham Heart Study. JAMA Internal Medicine. 180(9), 1225-1231.
- (2020). Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment. BRITISH JOURNAL OF CANCER.
- (2020). Re: Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population. JNCI-Journal of the National Cancer Institute. 112(5), 545-546.
- (2019). Divergent breast cancer incidence trends by hormone receptor status in the state of Sarawak, Malaysia. INTERNATIONAL JOURNAL OF CANCER. 147(3), 829-837.